Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML) (Annals of Hematology, 2019)

(untitled) - DiNardo, C; Stein, A; Stein, E; Fathi, A; Frankfurt, O; Schuh, A; Doehner, H; Martinelli, G; Patel, P; Raffoux, E; Tan, P; Zeidan, A; et al.